Package
Latest GlaxoSmithKline LLC Patents:
Description
The broken lines shown in the drawings depict portions of the package that form no part of the claimed design. The oblique shade lines in the drawings describe transparent areas of the package. In the front of the package, an opaque label is positioned inside of a transparent area of the article.
Claims
We claim the ornamental design for a package, as shown and described.
Referenced Cited
U.S. Patent Documents
D247222 | February 14, 1978 | Paone et al. |
D250092 | October 31, 1978 | Schoenfield et al. |
D283051 | March 18, 1986 | Fichera |
D305408 | January 9, 1990 | LaJoie |
D329600 | September 22, 1992 | LaJoie |
D330855 | November 10, 1992 | Demopoulos |
D331011 | November 17, 1992 | Karita |
D331012 | November 17, 1992 | Karita et al. |
D364803 | December 5, 1995 | Wada |
D365022 | December 12, 1995 | Wada |
D378570 | March 25, 1997 | MacEachern |
D378894 | April 22, 1997 | Mello |
D408279 | April 20, 1999 | Fracassi et al. |
D408280 | April 20, 1999 | Manley et al. |
D416483 | November 16, 1999 | Manley et al. |
D437216 | February 6, 2001 | Saputo et al. |
D442857 | May 29, 2001 | Feehan, Jr. |
D449780 | October 30, 2001 | Corella |
D451382 | December 4, 2001 | Adkins |
D453901 | February 26, 2002 | Shepperson |
D454782 | March 26, 2002 | Kropf et al. |
D502095 | February 22, 2005 | Tucker |
D504811 | May 10, 2005 | Haingaertner |
D541646 | May 1, 2007 | Hayes |
D556565 | December 4, 2007 | Nazari |
D584606 | January 13, 2009 | Wintmolders et al. |
D596023 | July 14, 2009 | Moskowitz |
D605516 | December 8, 2009 | Yang |
D606392 | December 22, 2009 | Prevost |
D615395 | May 11, 2010 | Jefferies |
D623935 | September 21, 2010 | Kim et al. |
D625181 | October 12, 2010 | Jefferies |
D645338 | September 20, 2011 | Kapur |
D653533 | February 7, 2012 | Brachman et al. |
D691880 | October 22, 2013 | Larson et al. |
D703551 | April 29, 2014 | Kirchmayr et al. |
D708056 | July 1, 2014 | Larson et al. |
D747964 | January 26, 2016 | Limback |
D767987 | October 4, 2016 | Wu |
D810558 | February 20, 2018 | Yuan |
D810560 | February 20, 2018 | Yuan |
D814292 | April 3, 2018 | Yuan |
D818818 | May 29, 2018 | Debnath |
D818820 | May 29, 2018 | Yuan |
D820674 | June 19, 2018 | Yuan |
20050092644 | May 5, 2005 | Cafferata et al. |
20110290688 | December 1, 2011 | Marcinkowski |
20170266873 | September 21, 2017 | Crosby |
Patent History
Patent number: D920093
Type: Grant
Filed: Nov 23, 2016
Date of Patent: May 25, 2021
Assignee: GlaxoSmithKline LLC (Wilmington, DE)
Inventors: Leonard Joseph DiChiara (Chatham, NJ), David Michael Lutness (Hillsborough, NJ), Jeffrey Scott Brunner (Parsippany, NJ), Peter Kay (Harlow), James Andrew Holt (Worthing)
Primary Examiner: Wendy L Arminio
Application Number: 29/585,377
Type: Grant
Filed: Nov 23, 2016
Date of Patent: May 25, 2021
Assignee: GlaxoSmithKline LLC (Wilmington, DE)
Inventors: Leonard Joseph DiChiara (Chatham, NJ), David Michael Lutness (Hillsborough, NJ), Jeffrey Scott Brunner (Parsippany, NJ), Peter Kay (Harlow), James Andrew Holt (Worthing)
Primary Examiner: Wendy L Arminio
Application Number: 29/585,377
Classifications
Current U.S. Class:
D9/415;
D9/425